Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Study of Pembrolizumab and Olaparib in Bile Duct Cancer

Study of Pembrolizumab and Olaparib in Bile Duct Cancer
Condition:   Cholangiocarcinoma
Interventions:   Drug: Pembrolizumab;   Drug: Olaparib
Sponsor:   Georgetown University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 13, 2020 / by / in
Comments